Trial record 11 of 714 for:    Open Studies | "Heart Failure"

Effects of a Walking Program and Inspiratory Muscle Training on Individuals With Chronic Heart Failure

This study is currently recruiting participants.
Verified November 2012 by Texas Woman's University
Sponsor:
Information provided by (Responsible Party):
Suh-Jen Lin, Texas Woman's University
ClinicalTrials.gov Identifier:
NCT01560871
First received: March 20, 2012
Last updated: November 8, 2012
Last verified: November 2012
  Purpose

Patients with chronic heart failure need a "safe and effective" exercise program that will improve their quality of life. For this study, we will determine if adult chronic heart failure patents assigned to an experimental exercise group of walking and Inspiratory Muscle Training (IMT) program will have an additional effect on respiratory muscle strength (PImax), cardiovascular endurance, quality of life, walking speed, heart rate variability, and physical activity level compared to subjects who are assigned to the home walking and "sham" Inspiratory Muscle Training (IMT) program.


Condition Intervention
Heart Failure NYHA Class III
Heart Failure NYHA Class II
Behavioral: High-intensity IMT plus walking
Behavioral: Low-intensity IMT plus walking

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of a Walking Program and Inspiratory Muscle Training on Individuals With Chronic Heart Failure - A Pilot Study

Resource links provided by NLM:


Further study details as provided by Texas Woman's University:

Primary Outcome Measures:
  • SF-36 Quality of Life questionnaire [ Time Frame: 6-week training ] [ Designated as safety issue: No ]
    The SF-36 quality of life questionnaire (short form) will be used.

  • Minnesota Living with Heart Failure Questionnaire [ Time Frame: 6-week training ] [ Designated as safety issue: No ]
    This questionnaire includes 21 questions which ask how much the heart condition affected the patient's life during the past month (4 weeks).


Secondary Outcome Measures:
  • Heart rate variability [ Time Frame: 6-week training ] [ Designated as safety issue: No ]
    A minimum of ten participants (5 in each group) will be selected randomly to record their 24-hour heart rate variability at home and return the unit at their next visit.

  • Physical Activity [ Time Frame: 6-week training ] [ Designated as safety issue: No ]
    Each subject will be given a pedometer to record his/her step counts every day. They will also wear a heart rate monitor while they walk. They will record their steps and average heart rate in the walking log.

  • respiratory muscle strength [ Time Frame: 6-week training ] [ Designated as safety issue: No ]
    The inspiratory muscle strength will be measured in the unit of cmH2O by the Respiratory Muscle meter (Micro Direct).

  • Six-minute walk test distance [ Time Frame: 6-week training ] [ Designated as safety issue: No ]
    The six-minute walk test is a measure of cardiovascular endurance which measures how far a person can walk in 6 minutes. This test will be conducted twice respectively at pre-training and also post-training to account for potential learning effect.


Estimated Enrollment: 30
Study Start Date: March 2012
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Sham Comparator: Walking and Low-intensity IMT
Inspiratory Muscle Training (IMT) intensity will be set at 15% PImax.
Behavioral: Low-intensity IMT plus walking

The IMT training is about 15-20 minutes. Both groups will need to come in once a week for 15 to 20 minutes to probably readjust the IMT training intensity on the breathing device.

For the walking program, each participant will be given a pedometer and a heart rate monitor so he/she can track daily step counts and walking heart rate during the study. The walking program will consist of walking every day at an intensity of "hard" to "somewhat hard" on the Rating of Perceived Exertion (RPE) scale. Participants will begin walking at least 15 minutes twice a day for 7 days a week and eventually progress to 45-50 minutes a day by the end of the six weeks.

Experimental: Walking and High-intensity IMT
Inspiratory Muscle Training (IMT) intensity will be set at 60% PImax.
Behavioral: High-intensity IMT plus walking

The IMT intensity will be set at 60% of PImax which will be adjusted weekly and nose clip will be used. Frequency: 5x/week; 1x/day preferred. 6 Interval Levels: (6 efforts at each level): (1) 60s rest interval; (2) 45s rest interval; (3) 30s rest interval; (4) 15s rest interval; (5)10s rest interval; (6) 5s rest interval, trained to exhaustion.

For the walking program, each participant will be given a pedometer and a heart rate monitor so he/she can track daily step counts and heart rate during the study. The walking program will consist of walking every day at an intensity of "hard" to "somewhat hard" on the Rating of Perceived Exertion (RPE) scale. Participants will begin walking at least 15 minutes twice a day for 7 days a week and eventually progress to 45-50 minutes a day by the end of the six weeks.


Detailed Description:

Participants will be recruited from the heart failure clinic at the St. Paul Hospital of UT Southwestern University in Dallas, TX, which is across the street from Texas Woman's University - Dallas Center. Flyers will be distributed to cardiologist there and posted on their bulletins. A research seminar reviewing the literature of inspiratory muscle training in patients with heart failure was given during the planning stage of the project, and those cardiologists were aware of the scope of the study and its inclusion and exclusion criteria of research participants. Potential research participants could call the research team for further information.

Participants will come to the first session where a history interview will be conducted to gather demographic data including age, race/ethnicity, and gender. We will measure height and weight and collect baseline data for the a) 6 minute walk test, b) respiratory muscle strength, c) comfortable walking speed, d) grip strength, and e) single limb stance time will be taken. Participants will also fill complete two quality of life questionnaires (SF-36, Minnesota Living with Heart Failure Questionnaire.

Each participant will be randomly assigned to one of two groups: a) a walking group with a high-intensity Inspiratory Muscle Training (IMT) program, OR a walking program with a sham IMT program. The Sham group will be trained at a low intensity and low repetitions. The training threshold for Experimental IMT arm will be set at 60% of PImax (high-intensity respiratory muscle training). The PImax will be adjusted weekly, nose clip used to ensure participant breathes completely through the mouth. Frequency: 5x/week; 1x/day preferred. 6 Interval Levels: (6 inspiratory efforts in each level): (1) 60s rest interval; (2) 45s rest interval; (3) 30s rest interval; (4) 15s rest interval; (5)10s rest interval; (6) 5s rest interval, trained to exhaustion. The sham IMT intensity will be set at fixed 15% PImax. Research participants will be blinded on the group assigned. The time commitment for their IMT training is about 15-20 minutes. Individuals from both research groups will come in to the School of Physical Therapy at Dallas Center once a week for 15 to 20 minutes to be tested and possibly re-adjust the IMT training intensity on the breathing device and to allow us to document their weekly step count.

Each participant will be given a pedometer and heart rate monitor so they can track their step counts and walking heart rate during the study. The walking program will consist of walking every day at an intensity of "hard" to "somewhat hard" on the Rating of Perceived Exertion (RPE) scale. Participants will begin walking at least 15 minutes twice a day for 7 days a week and eventually progress to 45-50 minutes a day by the end of the six weeks.

Depending on the availability of holter monitor heart rate recorder, a minimum of ten participants (5 in each group) will be selected randomly to record their 24-hour heart rate variability at home and return the unit at their next visit.

  Eligibility

Ages Eligible for Study:   18 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adults with chronic heart failure (Functional Class II-III)
  • BMI < 35 kg/m2, 18 to 75 years of age
  • PImax <70% predicted value
  • walk independently with or without assisted device
  • hospital discharge for CHF in the past three months.

Exclusion Criteria:

  • ECG with ventricular arrhythmia
  • pulmonary hypertension
  • COPD, emphysema, chronic bronchitis, bronchiectasis
  • history of falls, balance issues
  • smokers or patients who have ceased smoking within the past year
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01560871

Contacts
Contact: Suh-Jen Lin, PhD, PT 214-689-7718 slin@twu.edu

Locations
United States, Texas
School of Physical Therapy, Texas Woman's University Recruiting
Dallas, Texas, United States, 75235
Contact: Suh-Jen Lin, PT, PhD     214-689-7718     slin@twu.edu    
Principal Investigator: Suh-Jen Lin, PT, PhD            
Sponsors and Collaborators
Texas Woman's University
Investigators
Principal Investigator: Suh-Jen Lin, PhD, PT Texas Woman's University
  More Information

No publications provided

Responsible Party: Suh-Jen Lin, Associate Professor, Texas Woman's University
ClinicalTrials.gov Identifier: NCT01560871     History of Changes
Other Study ID Numbers: 16969
Study First Received: March 20, 2012
Last Updated: November 8, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Texas Woman's University:
Heart failure
inspiratory muscle training
physical activity

Additional relevant MeSH terms:
Respiratory Aspiration
Heart Failure
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 16, 2013